SCHEMBL19904550

SCHEMBL19904550

O=C(NC(Cc1cc(F)c2c(c1)OCCO2)CN1CCCC1)C1CCN(c2ccc3c(c2)CCCC3)C1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
UGCG Q16739 1/20 0.35
USP2 O75604 1/20 0.34
ALDH1A1 P00352 1/20 0.34
HPGD P15428 1/20 0.34
TSHR P16473 1/20 0.34
MAPK1 P28482 1/20 0.34
HTT P42858 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
HSD17B10 Q99714 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
SSTR3 P32745 3/20 0.34
KDM4E B2RXH2 2/20 0.34
CHRM4 P08173 1/20 0.34
SSTR1 P30872 1/20 0.34
PROKR2 Q8NFJ6 1/20 0.33
HTR1A P08908 1/20 0.33
NOTUM Q6P988 1/20 0.33
ACACB O00763 4/20 0.32
TRPV1 Q8NER1 1/20 0.32
STING1 Q86WV6 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19904563 1.00 UGCG (0.35) UGCGUSP2ALDH1A1HPGDTSHR
SCHEMBL19904389 0.90 UGCG (0.40) UGCGUSP2ALDH1A1HPGDTSHR
SCHEMBL19904542 0.90 UGCG (0.40) UGCGUSP2ALDH1A1HPGDTSHR
SCHEMBL19904605 0.89 ALDH1A1 (0.40) UGCGUSP2ALDH1A1HPGDTSHR
SCHEMBL19904452 0.89 ALDH1A1 (0.40) UGCGUSP2ALDH1A1HPGDTSHR
SCHEMBL19904427 0.89 KMT2A (0.38) UGCGUSP2ALDH1A1HPGDTSHR
SCHEMBL19904498 0.88 KDM4E (0.37) UGCGUSP2ALDH1A1HPGDTSHR
SCHEMBL19904561 0.88 MCHR1 (0.36) UGCGCHRM4HTR1A
SCHEMBL19904551 0.88 HTR1A (0.38) UGCGUSP2ALDH1A1HPGDTSHR
SCHEMBL19904368 0.88 HTR1A (0.38) UGCGUSP2ALDH1A1HPGDTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3063141-B1 N-(1-HYDROXY-3-(PYRROLIDINYL)PROPAN-2-YL)PYRROLIDINE-3-CARBOXAMIDE DERIVATIVES AS GLUCOSYLCERAMIDE SYNTHASE INHIBITORS BIOMARIN PHARM INC (US) 2018-02-28 EP disclosed